No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Distribution
Realcan Pharmaceutical Group Co., Ltd. operates as a global supplier, distributing pharmaceuticals, vaccines, medical devices, and consumable medical products to healthcare institutions across the world. Beyond its core distribution activities, the company offers a suite of specialized services, including comprehensive medical logistics, third-party logistics solutions, disinfection and sterilization, and equipment leasing, alongside full-service hospital logistics support. Its operational reach spans diverse areas such as drug distribution, academic support services, medical diagnostics, financial technology applications, traditional Chinese medicine, digital health solutions, professional logistics, and integrated equipment management. The company, initially incorporated as Realcan Pharmaceutical Co., Ltd., adopted its current designation in December 2018. Realcan was established in 2004 and is headquartered in Yantai, China.
www.realcan.cnNo one on the platform currently holds 002589.SZ.
No tracked institution reports a position in 002589.SZ as of their last filing.
No one on the platform has traded 002589.SZ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | — | — | — | |||
| Rev. Growth % | -8.4% | -23.2% | ||||
| Profit Margin % | 0.2% | -2.7% | -0.5% | |||
| Free Cash Flow Margin % | -0.2% | |||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $33.9B | — | $0.70 | $0.70–$0.70 | — | 1 |
| 2027 | $37.9B | +11.8% | $0.61 | $0.61–$0.61 | — | 1 |
| 2028 | $38.7B | +2.1% | $0.39 | $0.39–$0.39 | — | 1 |
| 2029 | $43.9B | +13.4% | $0.44 | $0.44–$0.44 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 0 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-22 | $0.37 | $0.00 | -99.3% |
| 2025-10-29 | $0.18 | $-0.00 | -102.2% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 002589.SZRealcan Pharmaceutical Group Co., Ltd. | $2.93 | -0.34% | $3.9B | — |
| 000705.SZZhejiang Zhenyuan Share Co., Ltd. | $6.80 | -1.16% | $2.3B | — |
| 002022.SZShanghai Kehua Bio-engineering Co., Ltd. | $5.50 | -0.90% | $2.8B | — |
| 002198.SZGuangdong Jiaying Pharmaceutical Co., Ltd | $3.58 | -1.65% | $1.8B | — |
| 002551.SZShenzhen Glory Medical Co.,Ltd. |
| $3.15 |
| -1.25% |
| $2.7B |
| — |
| 002788.SZLuyan Pharma Co.,Ltd. | $10.42 | -0.19% | $4.0B | — |
| 300562.SZGuangdong Transtek Medical Electronics Co., Ltd | $16.52 | -1.31% | $3.6B | — |
Source: Financial Modeling Prep · peers by sector/industry